Zentriforce Pharma

ZentriForce Pharma is a specialized contract research organization (CRO) providing high-end analytical services for the biopharmaceutical industry, with a particular focus on gene therapies and biosimilars. The company leverages cutting-edge instrumentation and deep scientific expertise, guided by a rigorous quality system aligned with WHO guidelines, to deliver data integrity and comprehensive analysis for its clients. Unlike a drug developer, ZentriForce operates as a critical service partner, enabling other companies to characterize complex molecules and advance their therapeutic programs through precise analytical data.

Specialized analytical services utilizing advanced biophysical techniques, primarily Analytical Ultracentrifugation (AUC) and Asymmetrical Flow Field-Flow Fractionation (AF4), combined with deep expertise in data interpretation for characterizing complex biologics, gene therapies, and peptides.

ZentriForce competes with other specialized analytical CROs and the in-house capabilities of large pharmaceutical companies. Its differentiation lies in its deep focus on complex techniques like AUC and AF4, its full-service consultative model, and its specific expertise in gene therapy vector analysis, a rapidly growing but technically challenging niche.